Society guideline links: Opportunistic infections in individuals with HIV

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: HIV infection in adolescents".)

●(See "Society guideline links: HIV treatment in nonpregnant adults".)

●(See "Society guideline links: HIV treatment in pregnant patients".)

●(See "Society guideline links: Primary care of adults with HIV".)

●(See "Society guideline links: Sexually transmitted infections".)

●(See "Society guideline links: Immunizations in persons with HIV".)

●(See "Society guideline links: Solid organ transplantation in individuals with HIV".)

●(See "Society guideline links: Acute diarrhea in adults".)

●(See "Society guideline links: Aspergillosis".)

●(See "Society guideline links: Candidiasis".)

●(See "Society guideline links: Chagas disease".)

●(See "Society guideline links: Coccidioidomycosis".)

●(See "Society guideline links: Cryptococcosis".)

●(See "Society guideline links: Management of hepatitis B".)

●(See "Society guideline links: Hepatitis C virus infection".)

●(See "Society guideline links: Molluscum contagiosum".)

●(See "Society guideline links: Nontuberculous mycobacteria".)

●(See "Society guideline links: Toxoplasmosis".)

●(See "Society guideline links: Diagnosis and treatment of tuberculosis".)

●(See "Society guideline links: Histoplasmosis".)

International

●World Health Organization (WHO): Consolidated guidelines on HIV prevention, testing, treatment, service delivery, and monitoring – Recommendations for a public health approach, update (2021)

Canada

●Choosing Wisely Canada: Don't routinely repeat CD4 measurements in patients with HIV infection with HIV-1 RNA suppression for >2 years and CD4 counts >500/microL, unless virologic failure occurs or intercurrent opportunistic infection develops (2022)

United States

●US Department of Health and Human Services (HHS): Federally approved clinical practice guidelines for HIV/AIDS

•Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV (2024)

•Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV (2024)

●American Academy of Pediatrics (AAP): Red Book – Human immunodeficiency virus infection (2024)

●International Antiviral Society-USA Panel (IAS-USA): Recommendations on antiretroviral drugs for treatment and prevention of HIV in adults (2024)

Europe

●European AIDS Clinical Society (EACS): Guidelines – Opportunistic infections and other co-infections (2024)

United Kingdom

●British HIV Association (BHIVA): Current guidelines – Opportunistic infection (OI)

•Guidelines on the management of opportunistic infection in people living with HIV – Considerations in pregnancy (2024)

•Guidelines on the management of opportunistic infection in people living with HIV – The clinical management of pulmonary opportunistic infections (2024)